Akanda Corp. (NASDAQ:AKAN – Get Free Report) saw a significant decline in short interest during the month of December. As of December 31st, there was short interest totaling 151,372 shares, a decline of 83.2% from the December 15th total of 903,214 shares. Based on an average daily volume of 4,767,598 shares, the short-interest ratio is currently 0.0 days. Currently, 41.6% of the shares of the stock are short sold. Currently, 41.6% of the shares of the stock are short sold. Based on an average daily volume of 4,767,598 shares, the short-interest ratio is currently 0.0 days.
Analyst Ratings Changes
AKAN has been the subject of a number of recent research reports. Wall Street Zen raised shares of Akanda to a “sell” rating in a research note on Saturday, October 18th. Weiss Ratings assumed coverage on Akanda in a research report on Wednesday, October 15th. They issued a “sell (e+)” rating for the company. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.
Check Out Our Latest Analysis on AKAN
Akanda Price Performance
About Akanda
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Read More
- Five stocks we like better than Akanda
- Wall Street ‘Sleeper Stock’ Could Become #1 Stock of 2026
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Gold Breakout ALERT
- Trump’s Hand-Written Letter Will Shock his Haters
- If You Keep Cash In A U.S. Bank Account… Read This NOW
Receive News & Ratings for Akanda Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akanda and related companies with MarketBeat.com's FREE daily email newsletter.
